<DOC>
	<DOCNO>NCT02103959</DOCNO>
	<brief_summary>The objective study evaluate CMX-2043 prevention renal cardiac injury associate coronary angiography patient acute coronary syndrome ( ACS ) , exclude ST-elevation myocardial infarction ( STEMI ) patient . This study specifically examine ability CMX-2043 prevent acute renal injury follow coronary angiography . The study also examine ability CMX 2043 prevention periprocedural cardiac injury . Information obtain relate ability CMX 2043 prevention major adverse cardiac renal event follow procedure . Additional information obtain study evaluate safety drug . Dose regimen information also obtain future clinical study CMX-2043 .</brief_summary>
	<brief_title>Safety Efficacy CMX-2043 Protection Heart Kidneys Subjects Undergoing Coronary Angiography</brief_title>
	<detailed_description />
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>1 . Male female subject least 18 year age . 2 . Subjects acute coronary syndrome ( exclude STEMI ) . 3 . Subjects undergo coronary angiography possibility go PCI . However , know patient unlikely undergo PCI , patient enrol . 4 . Subjects must meet either one follow criterion : 1 . An eGFR &lt; 45 mL/min determine MDRD equation 2 . An eGFR &lt; 60 mL/min determine MDRD equation least one following : . Over 75 year age ii . Diabetes mellitus iii . Ejection fraction le 40 % iv . Hypotension v. Congestive heart failure ( NYHA stage II high ) vi . Anemia ( hemoglobin 10 g/dL screen ) 5 . Female subject must also meet one follow criterion : 1 . Surgically sterile bilateral tubal ligation hysterectomy 2 . Postmenopausal least one year 3 . If childbearing potential , practice acceptable method birth control duration study judge investigator , condom , foam , jelly , diaphragm , intrauterine device abstinence . 6 . Subjects free noncardiac acute injury illnesses , opinion investigator , could put subject risk obscure interpretation result . 7 . Subjects willing undergo preand poststudy blood urine collection , physical exam laboratory investigation . 8 . Subjects willing provide sign write informed consent form . 1 . Subjects undergo elective coronary angiography ( i.e. , stable angina ) . 2 . Subjects endstage renal disease ( i.e. , eGFR &lt; 15 ) . 3 . Subjects STelevation myocardial infarction ( STEMI ) 4 . Subjects experience cardiac arrest associate current admission require chest compression cardiopulmonary resuscitation . 5 . Subjects experience life threaten arrhythmia associate current admission ventricular fibrillation ventricular tachycardia . 6 . Subjects weigh 125 kg . 7 . Subjects active history psychiatric disorder likely limit validity consent participate study limit ability comply protocol requirement . 8 . Subjects history alcohol drug abuse within one year screening . 9 . Subjects uncorrected clinically significant abnormality clinical laboratory test investigator opinion interfere study conduct . 10 . Subjects noncardiac acute illness injury investigator considers increase risk subject study 's success obscure interpretation result . 11 . Subject chronic disease consider investigator unfit procedure increase risk subject study 's success obscure interpretation result . 12 . Subjects currently enrol participate clinical study within 30 day screen within 5 halflives another study drug , whichever longer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>